| Symbol |
Name |
|
AASDH
|
aminoadipate-semialdehyde dehydrogenase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCE1
|
ATP-binding cassette, sub-family E (OABP), member 1
|
|
ABCF1
|
ATP-binding cassette, sub-family F (GCN20), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACADM
|
acyl-CoA dehydrogenase, C-4 to C-12 straight chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM23
|
ADAM metallopeptidase domain 23
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADGRE2
|
adhesion G protein-coupled receptor E2
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AFG3L2
|
AFG3-like AAA ATPase 2
|
|
AFP
|
alpha-fetoprotein
|
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
|
AGRP
|
agouti related neuropeptide
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIRE
|
autoimmune regulator
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALS2CL
|
ALS2 C-terminal like
|
|
AMELX
|
amelogenin, X-linked
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKRD54
|
ankyrin repeat domain 54
|
|
ANO3
|
anoctamin 3
|
|
AP2S1
|
adaptor-related protein complex 2, sigma 1 subunit
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOC2
|
apolipoprotein C-II
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARX
|
aristaless related homeobox
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ASMT
|
acetylserotonin O-methyltransferase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN2
|
ataxin 2
|
|
AURKB
|
aurora kinase B
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXIN1
|
axin 1
|
|
BABAM1
|
BRISC and BRCA1 A complex member 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BBS10
|
Bardet-Biedl syndrome 10
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2L14
|
BCL2-like 14 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEAN1
|
brain expressed, associated with NEDD4, 1
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIN1
|
bridging integrator 1
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMF
|
Bcl2 modifying factor
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTNL2
|
butyrophilin-like 2
|
|
C1GALT1C1
|
C1GALT1-specific chaperone 1
|
|
C1R
|
complement component 1, r subcomponent
|
|
C2ORF71
|
chromosome 2 open reading frame 71
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CACNA2D4
|
calcium channel, voltage-dependent, alpha 2/delta subunit 4
|
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CALR
|
calreticulin
|
|
CARD14
|
caspase recruitment domain family, member 14
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCND1
|
cyclin D1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCSER1
|
coiled-coil serine-rich protein 1
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD209
|
CD209 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD5
|
CD5 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD8A
|
CD8a molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDH8
|
cadherin 8, type 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEL
|
carboxyl ester lipase
|
|
CEP41
|
centrosomal protein 41kDa
|
|
CES1
|
carboxylesterase 1
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFI
|
complement factor I
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CHRNA2
|
cholinergic receptor, nicotinic, alpha 2 (neuronal)
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLDN16
|
claudin 16
|
|
CLPS
|
colipase, pancreatic
|
|
CLPTM1L
|
CLPTM1-like
|
|
CLU
|
clusterin
|
|
CNTN4
|
contactin 4
|
|
CNTNAP5
|
contactin associated protein-like 5
|
|
COL10A1
|
collagen, type X, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL8A1
|
collagen, type VIII, alpha 1
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX18
|
COX18 cytochrome c oxidase assembly factor
|
|
COX7B2
|
cytochrome c oxidase subunit VIIb2
|
|
CPT2
|
carnitine palmitoyltransferase 2
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSN3
|
casein kappa
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CST3
|
cystatin C
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTAGE5
|
CTAGE family, member 5
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTDP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTRC
|
chymotrypsin C (caldecrin)
|
|
CTSA
|
cathepsin A
|
|
CUX1
|
cut-like homeobox 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DCDC2
|
doublecortin domain containing 2
|
|
DCTN1
|
dynactin 1
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEL17Q12
|
Chromosome 17q12 deletion syndrome
|
|
DES
|
desmin
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DGAT1
|
diacylglycerol O-acyltransferase 1
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLD
|
dihydrolipoamide dehydrogenase
|
|
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1
|
|
DLGAP3
|
discs, large (Drosophila) homolog-associated protein 3
|
|
DMD
|
dystrophin
|
|
DNAJB2
|
DnaJ (Hsp40) homolog, subfamily B, member 2
|
|
DNAJC13
|
DnaJ (Hsp40) homolog, subfamily C, member 13
|
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DOK2
|
docking protein 2, 56kDa
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD4
|
dopamine receptor D4
|
|
DRD5
|
dopamine receptor D5
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DVL1
|
dishevelled segment polarity protein 1
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
DYM
|
dymeclin
|
|
DYNLRB1
|
dynein, light chain, roadblock-type 1
|
|
ECM1
|
extracellular matrix protein 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EMD
|
emerin
|
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A)
|
|
EPHB2
|
EPH receptor B2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERC1
|
ELKS/RAB6-interacting/CAST family member 1
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRB
|
estrogen-related receptor beta
|
|
ETV1
|
ets variant 1
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F11
|
coagulation factor XI
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FADS1
|
fatty acid desaturase 1
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FAS
|
Fas cell surface death receptor
|
|
FBN1
|
fibrillin 1
|
|
FBXO45
|
F-box protein 45
|
|
FBXO7
|
F-box protein 7
|
|
FBXW4
|
F-box and WD repeat domain containing 4
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF14
|
fibroblast growth factor 14
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FH
|
fumarate hydratase
|
|
FKBP6
|
FK506 binding protein 6, 36kDa
|
|
FKTN
|
fukutin
|
|
FLCN
|
folliculin
|
|
FLG
|
filaggrin
|
|
FLNC
|
filamin C, gamma
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOLR2
|
folate receptor 2 (fetal)
|
|
FOLR3
|
folate receptor 3 (gamma)
|
|
FOXC2
|
forkhead box C2
|
|
FOXE1
|
forkhead box E1
|
|
FOXL1
|
forkhead box L1
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FST
|
follistatin
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FZD6
|
frizzled class receptor 6
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GABRR1
|
gamma-aminobutyric acid (GABA) A receptor, rho 1
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GAP43
|
growth associated protein 43
|
|
GARS
|
glycyl-tRNA synthetase
|
|
GATA4
|
GATA binding protein 4
|
|
GATA5
|
GATA binding protein 5
|
|
GBA
|
glucosidase, beta, acid
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GDF9
|
growth differentiation factor 9
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIGYF2
|
GRB10 interacting GYF protein 2
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
|
GK
|
glycerol kinase
|
|
GLUD2
|
glutamate dehydrogenase 2
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
|
GNAS
|
GNAS complex locus
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GPHN
|
gephyrin
|
|
GPIHBP1
|
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
|
|
GPR148
|
G protein-coupled receptor 148
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRIN3A
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
|
|
GRM6
|
glutamate receptor, metabotropic 6
|
|
GRN
|
granulin
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H3F3A
|
H3 histone, family 3A
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBD
|
hemoglobin, delta
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HDC
|
histidine decarboxylase
|
|
HESX1
|
HESX homeobox 1
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
|
HFE
|
hemochromatosis
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPA3
|
heterogeneous nuclear ribonucleoprotein A3
|
|
HOXA1
|
homeobox A1
|
|
HOXA10
|
homeobox A10
|
|
HOXB13
|
homeobox B13
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HRH2
|
histamine receptor H2
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HYAL3
|
hyaluronoglucosaminidase 3
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL23R
|
interleukin 23 receptor
|
|
IL3
|
interleukin 3
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL6
|
interleukin 6
|
|
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INHA
|
inhibin, alpha
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNC3
|
potassium channel, voltage gated Shaw related subfamily C, member 3
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
|
KCNS1
|
potassium voltage-gated channel, modifier subfamily S, member 1
|
|
KCTD7
|
potassium channel tetramerization domain containing 7
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KEL
|
Kell blood group, metallo-endopeptidase
|
|
KERA
|
keratocan
|
|
KIAA0319
|
KIAA0319
|
|
KIF17
|
kinesin family member 17
|
|
KIF1A
|
kinesin family member 1A
|
|
KIF21A
|
kinesin family member 21A
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLK12
|
kallikrein-related peptidase 12
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNA1
|
karyopherin alpha 1 (importin alpha 5)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT16
|
keratin 16, type I
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT8
|
keratin 8, type II
|
|
KSR2
|
kinase suppressor of ras 2
|
|
KYNU
|
kynureninase
|
|
LACRT
|
lacritin
|
|
LCA5
|
Leber congenital amaurosis 5
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LDLRAP1
|
low density lipoprotein receptor adaptor protein 1
|
|
LEMD3
|
LEM domain containing 3
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX2
|
LIM homeobox 2
|
|
LHX3
|
LIM homeobox 3
|
|
LHX4
|
LIM homeobox 4
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase
|
|
LIPC
|
lipase, hepatic
|
|
LIPG
|
lipase, endothelial
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LMNB2
|
lamin B2
|
|
LOXHD1
|
lipoxygenase homology domains 1
|
|
LPL
|
lipoprotein lipase
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK1
|
leucine-rich repeat kinase 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LY96
|
lymphocyte antigen 96
|
|
MAOA
|
monoamine oxidase A
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARS
|
methionyl-tRNA synthetase
|
|
MAT2A
|
methionine adenosyltransferase II, alpha
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC4R
|
melanocortin 4 receptor
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEFV
|
Mediterranean fever
|
|
MEIS1
|
Meis homeobox 1
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR137
|
microRNA 137
|
|
MIR146A
|
microRNA 146a
|
|
MIR2682
|
microRNA 2682
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKS1
|
Meckel syndrome, type 1
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MPV17
|
MpV17 mitochondrial inner membrane protein
|
|
MPZ
|
myelin protein zero
|
|
MRAP2
|
melanocortin 2 receptor accessory protein 2
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRPL3
|
mitochondrial ribosomal protein L3
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTMR2
|
myotubularin related protein 2
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUTYH
|
mutY homolog
|
|
MVK
|
mevalonate kinase
|
|
MVP
|
major vault protein
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOCD
|
myocardin
|
|
MYOZ1
|
myozenin 1
|
|
MYOZ2
|
myozenin 2
|
|
NANOS3
|
nanos homolog 3 (Drosophila)
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCSTN
|
nicastrin
|
|
ND1
|
|
|
NDN
|
necdin, melanoma antigen (MAGE) family member
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NEUROG3
|
neurogenin 3
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NIPA2
|
non imprinted in Prader-Willi/Angelman syndrome 2
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NLGN1
|
neuroligin 1
|
|
NLGN3
|
neuroligin 3
|
|
NLGN4X
|
neuroligin 4, X-linked
|
|
NLGN4Y
|
neuroligin 4, Y-linked
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRP7
|
NLR family, pyrin domain containing 7
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPC1L1
|
NPC1-like 1
|
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
|
NPHP3
|
nephronophthisis 3 (adolescent)
|
|
NPHP4
|
nephronophthisis 4
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRGN
|
neurogranin (protein kinase C substrate, RC3)
|
|
NRXN1
|
neurexin 1
|
|
NRXN3
|
neurexin 3
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTF4
|
neurotrophin 4
|
|
NTNG1
|
netrin G1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUCB2
|
nucleobindin 2
|
|
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUP98
|
nucleoporin 98kDa
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OFCC1
|
orofacial cleft 1 candidate 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
OTOS
|
otospiralin
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PAH
|
phenylalanine hydroxylase
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PARD6A
|
par-6 family cell polarity regulator alpha
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PAX2
|
paired box 2
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX7
|
paired box 7
|
|
PAX8
|
paired box 8
|
|
PCDH19
|
protocadherin 19
|
|
PCDH8
|
protocadherin 8
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDYN
|
prodynorphin
|
|
PER3
|
period circadian clock 3
|
|
PFN1
|
profilin 1
|
|
PGM3
|
phosphoglucomutase 3
|
|
PGR
|
progesterone receptor
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHLDA3
|
pleckstrin homology-like domain, family A, member 3
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PINX1
|
PIN2/TERF1 interacting, telomerase inhibitor 1
|
|
PITX3
|
paired-like homeodomain 3
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLD3
|
phospholipase D family, member 3
|
|
PLEKHG4
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 4
|
|
PLN
|
phospholamban
|
|
PLXNA2
|
plexin A2
|
|
PLXNA4
|
plexin A4
|
|
PML
|
promyelocytic leukemia
|
|
PMP22
|
peripheral myelin protein 22
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLR3B
|
polymerase (RNA) III (DNA directed) polypeptide B
|
|
PON1
|
paraoxonase 1
|
|
POT1
|
protection of telomeres 1
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PQBP1
|
polyglutamine binding protein 1
|
|
PRDM16
|
PR domain containing 16
|
|
PRDM9
|
PR domain containing 9
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRM1
|
protamine 1
|
|
PRM2
|
protamine 2
|
|
PRNP
|
prion protein
|
|
PROCR
|
protein C receptor, endothelial
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROM1
|
prominin 1
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRPF3
|
pre-mRNA processing factor 3
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PRRX1
|
paired related homeobox 1
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PRSS2
|
protease, serine, 2 (trypsin 2)
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSENEN
|
presenilin enhancer gamma secretase subunit
|
|
PTCHD3
|
patched domain containing 3
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYY
|
peptide YY
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB6C
|
RAB6C, member RAS oncogene family
|
|
RAB7A
|
RAB7A, member RAS oncogene family
|
|
RABL2A
|
RAB, member of RAS oncogene family-like 2A
|
|
RABL2B
|
RAB, member of RAS oncogene family-like 2B
|
|
RAD51
|
RAD51 recombinase
|
|
RAD51B
|
RAD51 paralog B
|
|
RAD51C
|
RAD51 paralog C
|
|
RAD51D
|
RAD51 paralog D
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7
|
|
RB1
|
retinoblastoma 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RD3
|
retinal degeneration 3
|
|
REEP1
|
receptor accessory protein 1
|
|
RET
|
ret proto-oncogene
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHD
|
Rh blood group, D antigen
|
|
RNF114
|
ring finger protein 114
|
|
RNF186
|
ring finger protein 186
|
|
RNF31
|
ring finger protein 31
|
|
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila)
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPGRIP1L
|
RPGRIP1-like
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RYK
|
receptor-like tyrosine kinase
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SBF2
|
SET binding factor 2
|
|
SCARB2
|
scavenger receptor class B, member 2
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SDC1
|
syndecan 1
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SETBP1
|
SET binding protein 1
|
|
SETD5
|
SET domain containing 5
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SI
|
sucrase-isomaltase (alpha-glucosidase)
|
|
SIAE
|
sialic acid acetylesterase
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC14A1
|
solute carrier family 14 (urea transporter), member 1 (Kidd blood group)
|
|
SLC17A6
|
solute carrier family 17 (vesicular glutamate transporter), member 6
|
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
|
SLC35C1
|
solute carrier family 35 (GDP-fucose transporter), member C1
|
|
SLC39A4
|
solute carrier family 39 (zinc transporter), member 4
|
|
SLC41A1
|
solute carrier family 41 (magnesium transporter), member 1
|
|
SLC6A19
|
solute carrier family 6 (neutral amino acid transporter), member 19
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SLITRK1
|
SLIT and NTRK-like family, member 1
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNTA1
|
syntrophin, alpha 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOST
|
sclerostin
|
|
SPATA7
|
spermatogenesis associated 7
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPOP
|
speckle-type POZ protein
|
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRY
|
sex determining region Y
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
STAG2
|
stromal antigen 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
TAC3
|
tachykinin 3
|
|
TACR3
|
tachykinin receptor 3
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBP
|
TATA box binding protein
|
|
TBX1
|
T-box 1
|
|
TBX2
|
T-box 2
|
|
TBX3
|
T-box 3
|
|
TBX6
|
T-box 6
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TBXAS1
|
thromboxane A synthase 1 (platelet)
|
|
TECTA
|
tectorin alpha
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TFF1
|
trefoil factor 1
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM132D
|
transmembrane protein 132D
|
|
TMEM18
|
transmembrane protein 18
|
|
TMEM67
|
transmembrane protein 67
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNXB
|
tenascin XB
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAPPC2
|
trafficking protein particle complex 2
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase
|
|
TRIT1
|
tRNA isopentenyltransferase 1
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTBK2
|
tau tubulin kinase 2
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TUBB2A
|
tubulin, beta 2A class IIa
|
|
TULP1
|
tubby like protein 1
|
|
TYK2
|
tyrosine kinase 2
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
|
UBA1
|
ubiquitin-like modifier activating enzyme 1
|
|
UBQLN1
|
ubiquilin 1
|
|
UBQLN2
|
ubiquilin 2
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
ULK4
|
unc-51 like kinase 4
|
|
UMOD
|
uromodulin
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
|
UPK3A
|
uroplakin 3A
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
USP9Y
|
ubiquitin specific peptidase 9, Y-linked
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VAX1
|
ventral anterior homeobox 1
|
|
VCP
|
valosin containing protein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS35
|
vacuolar protein sorting 35 homolog (S. cerevisiae)
|
|
VWF
|
von Willebrand factor
|
|
WDR36
|
WD repeat domain 36
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
ZIC2
|
Zic family member 2
|
|
ZNF384
|
zinc finger protein 384
|
|
ZNF469
|
zinc finger protein 469
|
|
ZNF480
|
zinc finger protein 480
|
|
ZNF592
|
zinc finger protein 592
|
|
ZNF750
|
zinc finger protein 750
|
|
ZNF804A
|
zinc finger protein 804A
|
